Advertisement
Screener

Freeline Therapeutics Holdings plc Increase (Decrease) in Accounts Payable

Freeline Therapeutics Holdings plc Increase (Decrease) in Accounts Payable

Freeline Therapeutics Holdings plc reported Increase (Decrease) in Accounts Payable of $518.00 thousand for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-12-01

  • Freeline Therapeutics Holdings plc increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $1.11M, a 37.37% decline year-over-year.
  • Freeline Therapeutics Holdings plc increase (decrease) in accounts payable for the quarter ending 2023-06-30 was -$2.68M.
  • Freeline Therapeutics Holdings plc increase (decrease) in accounts payable for the quarter ending 2023-03-31 was $2.09M, a 50.14% decline year-over-year.
  • Freeline Therapeutics Holdings plc increase (decrease) in accounts payable for the quarter ending 2022-12-31 was $229.00K.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2023-09-30$1.11M
derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01
-$1.57M
derived: sum of 2 quarters · filed 2023-12-01
$518.00K
6-K · filed 2023-12-01
$747.00K
derived: sum of 4 quarters · filed 2023-12-01
2023-06-30-$2.68M
derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15
-$593.00K
6-K · filed 2023-08-15
-$364.00K
derived: sum of 3 quarters · filed 2023-08-15
$1.41M
derived: sum of 4 quarters · filed 2023-12-01
2023-03-31$2.09M
6-K · filed 2023-05-30
$2.32M
derived: sum of 2 quarters · filed 2023-05-30
$4.09M
derived: sum of 3 quarters · filed 2023-12-01
$3.34M
derived: sum of 4 quarters · filed 2023-12-01
2022-12-31$229.00K
derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04
$2.00M
derived: sum of 2 quarters · filed 2023-12-01
$1.25M
derived: sum of 3 quarters · filed 2023-12-01
$5.45M
20-F · filed 2023-04-04
2022-09-30$1.77M
derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01
$1.02M
derived: sum of 2 quarters · filed 2023-12-01
$5.22M
6-K · filed 2023-12-01
$4.73M
derived: sum of 4 quarters · filed 2023-12-01
2022-06-30-$751.00K
derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15
$3.44M
6-K · filed 2023-08-15
$2.95M
derived: sum of 3 quarters · filed 2023-08-15
$4.30M
derived: sum of 4 quarters · filed 2023-08-15
2022-03-31$4.19M
6-K · filed 2023-05-30
$3.70M
derived: sum of 2 quarters · filed 2023-05-30
$5.05M
derived: sum of 3 quarters · filed 2023-05-30
$3.88M
derived: sum of 4 quarters · filed 2023-05-30
2021-12-31-$490.00K
derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04
$858.00K
derived: sum of 2 quarters · filed 2023-04-04
-$309.00K
derived: sum of 3 quarters · filed 2023-04-04
-$2.89M
20-F · filed 2023-04-04
2021-09-30$1.35M
derived: 6-K 9 month − 6-K 6 month · filed 2022-11-15
$181.00K
derived: sum of 2 quarters · filed 2022-11-15
-$2.40M
6-K · filed 2022-11-15
-$484.00K
derived: sum of 4 quarters · filed 2023-04-04
2021-06-30-$1.17M
derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09
-$3.75M
6-K · filed 2022-08-09
-$1.83M
derived: sum of 3 quarters · filed 2023-04-04
-$9.72M
derived: sum of 4 quarters · filed 2023-04-04
2021-03-31-$2.58M
6-K · filed 2022-05-10
-$665.00K
derived: sum of 2 quarters · filed 2023-04-04
-$8.56M
derived: sum of 3 quarters · filed 2023-04-04
-$2.57M
derived: sum of 4 quarters · filed 2023-04-04
2020-12-31$1.92M
derived: 20-F 12 month − 6-K 9 month · filed 2023-04-04
-$5.98M
derived: sum of 2 quarters · filed 2023-04-04
$12.00K
derived: sum of 3 quarters · filed 2023-04-04
$1.54M
20-F · filed 2023-04-04
2020-09-30-$7.89M
derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09
-$1.90M
derived: sum of 2 quarters · filed 2021-11-09
-$376.00K
6-K · filed 2021-11-09
2020-06-30$5.99M
derived: 6-K 6 month − 6-K 3 month · filed 2021-08-16
$7.52M
6-K · filed 2021-08-16
2020-03-31$1.53M
6-K · filed 2021-05-17
2019-12-31$4.13M
20-F · filed 2022-03-31
2019-06-30$1.12M
6-K · filed 2020-10-29
2018-12-31$7.53M
20-F · filed 2021-03-31